In the News

In The News

Learn more about Emergent CDMO’s work and the many milestones we’ve reached in our news release archive below. If you’re a media representative, please feel free to contact our media relations office at mediarelations@ebsi.com.

Should you be interested in learning more about Emergent BioSolutions Inc.(NYSE: EBS), please visit our corporate Newsroom.

10.27.2022

SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions

SIOUX FALLS, S.D. and GAITHERSBURG, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), ("SAB”), a...

09.01.2022

EXECUTIVE INTERVIEW – Emergent CDMO: A Molecule-to-Market Partner for Complex Biologics

For nearly 25 years, Emergent has developed, manufactured, and delivered their own innovative vaccines and biotherapeutic...

03.21.2022

Four Key Considerations to Help Prepare for the Next Public Health Threat

As a CDMO, Emergent has been working for more than two decades to develop, manufacture, and deliver protections against public...

03.14.2022

Emergent Announces Additions to Leadership Team

Emergent is pleased to announce the addition of two senior leaders to its CDMO and Quality & Compliance organizations.

03.11.2022

The Path to Reemergence

Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions recently shared his insights with Pharma...

07.23.2021

Arrival of the Groninger INTEGRA

With the expansion of our viral drug product manufacturing facility in Rockville, Maryland well underway, we have begun...